viernes, 29 de mayo de 2020

Vertex angers U.K. cystic fibrosis patients with delay on new drug data

Vertex angers U.K. cystic fibrosis patients with delay on new drug data

Daily Recap

















STAT Plus: Vertex angers U.K. cystic fibrosis patients with a delay in submitting data for its newest therapy

By ED SILVERMAN


BILL SIKES/AP
Vertex has sparked anger among cystic fibrosis patients by requesting extra time to submit evidence for a new therapy to a U.K. cost-effectiveness agency

No hay comentarios:

Publicar un comentario